nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP1A2—Carmustine—lymphatic system cancer	0.0893	0.147	CbGbCtD
Amiodarone—CYP3A5—Teniposide—lymphatic system cancer	0.0806	0.132	CbGbCtD
Amiodarone—CYP2C19—Teniposide—lymphatic system cancer	0.065	0.107	CbGbCtD
Amiodarone—CYP2C9—Teniposide—lymphatic system cancer	0.0541	0.0888	CbGbCtD
Amiodarone—CYP3A7—Vincristine—lymphatic system cancer	0.0517	0.0849	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0517	0.0849	CbGbCtD
Amiodarone—CYP3A5—Vincristine—lymphatic system cancer	0.0388	0.0637	CbGbCtD
Amiodarone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0367	0.0603	CbGbCtD
Amiodarone—CYP3A4—Cytarabine—lymphatic system cancer	0.0319	0.0524	CbGbCtD
Amiodarone—CYP3A4—Teniposide—lymphatic system cancer	0.0314	0.0516	CbGbCtD
Amiodarone—ABCB1—Vincristine—lymphatic system cancer	0.0253	0.0415	CbGbCtD
Amiodarone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.022	0.0361	CbGbCtD
Amiodarone—ABCB1—Methotrexate—lymphatic system cancer	0.0153	0.0251	CbGbCtD
Amiodarone—CYP3A4—Vincristine—lymphatic system cancer	0.0151	0.0248	CbGbCtD
Amiodarone—EBP—Azacitidine—Fludarabine—lymphatic system cancer	0.00215	0.514	CbGdCrCtD
Amiodarone—EBP—Azacitidine—Cytarabine—lymphatic system cancer	0.00203	0.486	CbGdCrCtD
Amiodarone—Skin discolouration—Methotrexate—lymphatic system cancer	0.000512	0.00132	CcSEcCtD
Amiodarone—Sweating—Vincristine—lymphatic system cancer	0.000511	0.00132	CcSEcCtD
Amiodarone—Renal failure—Mitoxantrone—lymphatic system cancer	0.000511	0.00132	CcSEcCtD
Amiodarone—Nausea—Mechlorethamine—lymphatic system cancer	0.00051	0.00132	CcSEcCtD
Amiodarone—Alopecia—Bleomycin—lymphatic system cancer	0.000508	0.00131	CcSEcCtD
Amiodarone—Jaundice—Mitoxantrone—lymphatic system cancer	0.000506	0.00131	CcSEcCtD
Amiodarone—Urticaria—Teniposide—lymphatic system cancer	0.000503	0.0013	CcSEcCtD
Amiodarone—Abdominal pain—Teniposide—lymphatic system cancer	0.000501	0.00129	CcSEcCtD
Amiodarone—Body temperature increased—Teniposide—lymphatic system cancer	0.000501	0.00129	CcSEcCtD
Amiodarone—Erythema—Bleomycin—lymphatic system cancer	0.0005	0.00129	CcSEcCtD
Amiodarone—Paraesthesia—Fludarabine—lymphatic system cancer	0.0005	0.00129	CcSEcCtD
Amiodarone—Hallucination—Carmustine—lymphatic system cancer	0.000499	0.00129	CcSEcCtD
Amiodarone—Sweating—Mitoxantrone—lymphatic system cancer	0.000498	0.00129	CcSEcCtD
Amiodarone—Dyspnoea—Fludarabine—lymphatic system cancer	0.000496	0.00128	CcSEcCtD
Amiodarone—Dyspepsia—Fludarabine—lymphatic system cancer	0.00049	0.00127	CcSEcCtD
Amiodarone—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000485	0.00125	CcSEcCtD
Amiodarone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000484	0.00125	CcSEcCtD
Amiodarone—Visual impairment—Carmustine—lymphatic system cancer	0.000483	0.00125	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000481	0.00124	CcSEcCtD
Amiodarone—Fatigue—Fludarabine—lymphatic system cancer	0.00048	0.00124	CcSEcCtD
Amiodarone—Inflammation—Methotrexate—lymphatic system cancer	0.000477	0.00123	CcSEcCtD
Amiodarone—Hallucination—Vincristine—lymphatic system cancer	0.000476	0.00123	CcSEcCtD
Amiodarone—Constipation—Fludarabine—lymphatic system cancer	0.000476	0.00123	CcSEcCtD
Amiodarone—Pain—Fludarabine—lymphatic system cancer	0.000476	0.00123	CcSEcCtD
Amiodarone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000475	0.00123	CcSEcCtD
Amiodarone—Vasculitis—Methotrexate—lymphatic system cancer	0.000474	0.00123	CcSEcCtD
Amiodarone—Hypersensitivity—Teniposide—lymphatic system cancer	0.000467	0.00121	CcSEcCtD
Amiodarone—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000466	0.00121	CcSEcCtD
Amiodarone—Flushing—Carmustine—lymphatic system cancer	0.000465	0.0012	CcSEcCtD
Amiodarone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000464	0.0012	CcSEcCtD
Amiodarone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000459	0.00119	CcSEcCtD
Amiodarone—Asthenia—Teniposide—lymphatic system cancer	0.000455	0.00117	CcSEcCtD
Amiodarone—Malaise—Bleomycin—lymphatic system cancer	0.000451	0.00117	CcSEcCtD
Amiodarone—Pruritus—Teniposide—lymphatic system cancer	0.000448	0.00116	CcSEcCtD
Amiodarone—Arrhythmia—Carmustine—lymphatic system cancer	0.000448	0.00116	CcSEcCtD
Amiodarone—Alopecia—Carmustine—lymphatic system cancer	0.000443	0.00115	CcSEcCtD
Amiodarone—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000442	0.00114	CcSEcCtD
Amiodarone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00044	0.00114	CcSEcCtD
Amiodarone—Erythema—Carmustine—lymphatic system cancer	0.000437	0.00113	CcSEcCtD
Amiodarone—Cough—Bleomycin—lymphatic system cancer	0.000436	0.00113	CcSEcCtD
Amiodarone—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000434	0.00112	CcSEcCtD
Amiodarone—Diarrhoea—Teniposide—lymphatic system cancer	0.000433	0.00112	CcSEcCtD
Amiodarone—Alopecia—Vincristine—lymphatic system cancer	0.000423	0.00109	CcSEcCtD
Amiodarone—Back pain—Carmustine—lymphatic system cancer	0.000422	0.00109	CcSEcCtD
Amiodarone—Discomfort—Bleomycin—lymphatic system cancer	0.000421	0.00109	CcSEcCtD
Amiodarone—Ecchymosis—Methotrexate—lymphatic system cancer	0.000418	0.00108	CcSEcCtD
Amiodarone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000417	0.00108	CcSEcCtD
Amiodarone—Alopecia—Mitoxantrone—lymphatic system cancer	0.000412	0.00106	CcSEcCtD
Amiodarone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000412	0.00106	CcSEcCtD
Amiodarone—Confusional state—Bleomycin—lymphatic system cancer	0.000412	0.00106	CcSEcCtD
Amiodarone—Vision blurred—Carmustine—lymphatic system cancer	0.000411	0.00106	CcSEcCtD
Amiodarone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00041	0.00106	CcSEcCtD
Amiodarone—Tremor—Carmustine—lymphatic system cancer	0.000409	0.00106	CcSEcCtD
Amiodarone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000408	0.00106	CcSEcCtD
Amiodarone—Oedema—Bleomycin—lymphatic system cancer	0.000408	0.00106	CcSEcCtD
Amiodarone—Erythema—Mitoxantrone—lymphatic system cancer	0.000406	0.00105	CcSEcCtD
Amiodarone—Infection—Bleomycin—lymphatic system cancer	0.000406	0.00105	CcSEcCtD
Amiodarone—Back pain—Vincristine—lymphatic system cancer	0.000403	0.00104	CcSEcCtD
Amiodarone—Vomiting—Teniposide—lymphatic system cancer	0.000403	0.00104	CcSEcCtD
Amiodarone—Agitation—Carmustine—lymphatic system cancer	0.000401	0.00104	CcSEcCtD
Amiodarone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0004	0.00103	CcSEcCtD
Amiodarone—Asthenia—Fludarabine—lymphatic system cancer	0.000399	0.00103	CcSEcCtD
Amiodarone—Rash—Teniposide—lymphatic system cancer	0.000399	0.00103	CcSEcCtD
Amiodarone—Dermatitis—Teniposide—lymphatic system cancer	0.000399	0.00103	CcSEcCtD
Amiodarone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000398	0.00103	CcSEcCtD
Amiodarone—Headache—Teniposide—lymphatic system cancer	0.000397	0.00103	CcSEcCtD
Amiodarone—Pruritus—Fludarabine—lymphatic system cancer	0.000394	0.00102	CcSEcCtD
Amiodarone—Back pain—Mitoxantrone—lymphatic system cancer	0.000393	0.00101	CcSEcCtD
Amiodarone—Anorexia—Bleomycin—lymphatic system cancer	0.000389	0.00101	CcSEcCtD
Amiodarone—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000388	0.001	CcSEcCtD
Amiodarone—Agitation—Vincristine—lymphatic system cancer	0.000383	0.00099	CcSEcCtD
Amiodarone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000383	0.000989	CcSEcCtD
Amiodarone—Photosensitivity—Methotrexate—lymphatic system cancer	0.000382	0.000988	CcSEcCtD
Amiodarone—Hypotension—Bleomycin—lymphatic system cancer	0.000381	0.000986	CcSEcCtD
Amiodarone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000381	0.000985	CcSEcCtD
Amiodarone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000377	0.000973	CcSEcCtD
Amiodarone—Nausea—Teniposide—lymphatic system cancer	0.000376	0.000973	CcSEcCtD
Amiodarone—Vertigo—Vincristine—lymphatic system cancer	0.000374	0.000968	CcSEcCtD
Amiodarone—Hepatic failure—Methotrexate—lymphatic system cancer	0.000374	0.000966	CcSEcCtD
Amiodarone—Anxiety—Carmustine—lymphatic system cancer	0.00037	0.000957	CcSEcCtD
Amiodarone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000367	0.000947	CcSEcCtD
Amiodarone—Malaise—Mitoxantrone—lymphatic system cancer	0.000366	0.000946	CcSEcCtD
Amiodarone—Dyspnoea—Bleomycin—lymphatic system cancer	0.000364	0.000941	CcSEcCtD
Amiodarone—Renal failure acute—Methotrexate—lymphatic system cancer	0.000364	0.00094	CcSEcCtD
Amiodarone—Confusional state—Carmustine—lymphatic system cancer	0.000359	0.000929	CcSEcCtD
Amiodarone—Oedema—Carmustine—lymphatic system cancer	0.000356	0.000921	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000356	0.00092	CcSEcCtD
Amiodarone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000355	0.000917	CcSEcCtD
Amiodarone—Visual disturbance—Methotrexate—lymphatic system cancer	0.000354	0.000916	CcSEcCtD
Amiodarone—Cough—Mitoxantrone—lymphatic system cancer	0.000354	0.000915	CcSEcCtD
Amiodarone—Infection—Carmustine—lymphatic system cancer	0.000354	0.000915	CcSEcCtD
Amiodarone—Vomiting—Fludarabine—lymphatic system cancer	0.000354	0.000915	CcSEcCtD
Amiodarone—Rash—Fludarabine—lymphatic system cancer	0.000351	0.000907	CcSEcCtD
Amiodarone—Dermatitis—Fludarabine—lymphatic system cancer	0.000351	0.000906	CcSEcCtD
Amiodarone—Pain—Bleomycin—lymphatic system cancer	0.000349	0.000902	CcSEcCtD
Amiodarone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000349	0.000902	CcSEcCtD
Amiodarone—Headache—Fludarabine—lymphatic system cancer	0.000349	0.000901	CcSEcCtD
Amiodarone—Tachycardia—Carmustine—lymphatic system cancer	0.000348	0.000899	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000347	0.000897	CcSEcCtD
Amiodarone—Anxiety—Mitoxantrone—lymphatic system cancer	0.000344	0.00089	CcSEcCtD
Amiodarone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000341	0.000882	CcSEcCtD
Amiodarone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00034	0.000879	CcSEcCtD
Amiodarone—Oedema—Vincristine—lymphatic system cancer	0.00034	0.000879	CcSEcCtD
Amiodarone—Anorexia—Carmustine—lymphatic system cancer	0.00034	0.000878	CcSEcCtD
Amiodarone—Infection—Vincristine—lymphatic system cancer	0.000338	0.000873	CcSEcCtD
Amiodarone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000336	0.000869	CcSEcCtD
Amiodarone—Confusional state—Mitoxantrone—lymphatic system cancer	0.000334	0.000863	CcSEcCtD
Amiodarone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000333	0.000861	CcSEcCtD
Amiodarone—Hypotension—Carmustine—lymphatic system cancer	0.000333	0.000861	CcSEcCtD
Amiodarone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000331	0.000856	CcSEcCtD
Amiodarone—Oedema—Mitoxantrone—lymphatic system cancer	0.000331	0.000856	CcSEcCtD
Amiodarone—Nausea—Fludarabine—lymphatic system cancer	0.000331	0.000855	CcSEcCtD
Amiodarone—Infection—Mitoxantrone—lymphatic system cancer	0.000329	0.000851	CcSEcCtD
Amiodarone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000329	0.00085	CcSEcCtD
Amiodarone—Shock—Mitoxantrone—lymphatic system cancer	0.000326	0.000842	CcSEcCtD
Amiodarone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000324	0.000838	CcSEcCtD
Amiodarone—Urticaria—Bleomycin—lymphatic system cancer	0.000324	0.000838	CcSEcCtD
Amiodarone—Anorexia—Vincristine—lymphatic system cancer	0.000324	0.000838	CcSEcCtD
Amiodarone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000323	0.000836	CcSEcCtD
Amiodarone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000323	0.000834	CcSEcCtD
Amiodarone—Insomnia—Carmustine—lymphatic system cancer	0.000322	0.000833	CcSEcCtD
Amiodarone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000322	0.000832	CcSEcCtD
Amiodarone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00032	0.000828	CcSEcCtD
Amiodarone—Paraesthesia—Carmustine—lymphatic system cancer	0.00032	0.000827	CcSEcCtD
Amiodarone—Hypotension—Vincristine—lymphatic system cancer	0.000318	0.000822	CcSEcCtD
Amiodarone—Dyspnoea—Carmustine—lymphatic system cancer	0.000318	0.000821	CcSEcCtD
Amiodarone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000316	0.000816	CcSEcCtD
Amiodarone—Ataxia—Methotrexate—lymphatic system cancer	0.000316	0.000816	CcSEcCtD
Amiodarone—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00031	0.000801	CcSEcCtD
Amiodarone—Decreased appetite—Carmustine—lymphatic system cancer	0.00031	0.000801	CcSEcCtD
Amiodarone—Hypotension—Mitoxantrone—lymphatic system cancer	0.00031	0.0008	CcSEcCtD
Amiodarone—Insomnia—Vincristine—lymphatic system cancer	0.000308	0.000795	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000308	0.000795	CcSEcCtD
Amiodarone—Paraesthesia—Vincristine—lymphatic system cancer	0.000305	0.000789	CcSEcCtD
Amiodarone—Pain—Carmustine—lymphatic system cancer	0.000305	0.000788	CcSEcCtD
Amiodarone—Constipation—Carmustine—lymphatic system cancer	0.000305	0.000788	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000302	0.000782	CcSEcCtD
Amiodarone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000301	0.000777	CcSEcCtD
Amiodarone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000297	0.000769	CcSEcCtD
Amiodarone—Decreased appetite—Vincristine—lymphatic system cancer	0.000296	0.000764	CcSEcCtD
Amiodarone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000295	0.000763	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000294	0.000759	CcSEcCtD
Amiodarone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000294	0.000759	CcSEcCtD
Amiodarone—Fatigue—Vincristine—lymphatic system cancer	0.000293	0.000758	CcSEcCtD
Amiodarone—Asthenia—Bleomycin—lymphatic system cancer	0.000293	0.000757	CcSEcCtD
Amiodarone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000292	0.000754	CcSEcCtD
Amiodarone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000291	0.000753	CcSEcCtD
Amiodarone—Constipation—Vincristine—lymphatic system cancer	0.000291	0.000752	CcSEcCtD
Amiodarone—Pain—Vincristine—lymphatic system cancer	0.000291	0.000752	CcSEcCtD
Amiodarone—Pruritus—Bleomycin—lymphatic system cancer	0.000289	0.000746	CcSEcCtD
Amiodarone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000288	0.000744	CcSEcCtD
Amiodarone—Eosinophilia—Methotrexate—lymphatic system cancer	0.000287	0.000743	CcSEcCtD
Amiodarone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000286	0.000738	CcSEcCtD
Amiodarone—Pancreatitis—Methotrexate—lymphatic system cancer	0.000285	0.000735	CcSEcCtD
Amiodarone—Pain—Mitoxantrone—lymphatic system cancer	0.000283	0.000732	CcSEcCtD
Amiodarone—Constipation—Mitoxantrone—lymphatic system cancer	0.000283	0.000732	CcSEcCtD
Amiodarone—Abdominal pain—Carmustine—lymphatic system cancer	0.000282	0.000728	CcSEcCtD
Amiodarone—Body temperature increased—Carmustine—lymphatic system cancer	0.000282	0.000728	CcSEcCtD
Amiodarone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000278	0.000719	CcSEcCtD
Amiodarone—Pancytopenia—Methotrexate—lymphatic system cancer	0.000276	0.000712	CcSEcCtD
Amiodarone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000273	0.000706	CcSEcCtD
Amiodarone—Neutropenia—Methotrexate—lymphatic system cancer	0.000271	0.000701	CcSEcCtD
Amiodarone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000271	0.0007	CcSEcCtD
Amiodarone—Abdominal pain—Vincristine—lymphatic system cancer	0.000269	0.000695	CcSEcCtD
Amiodarone—Body temperature increased—Vincristine—lymphatic system cancer	0.000269	0.000695	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000267	0.000691	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000265	0.000685	CcSEcCtD
Amiodarone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000263	0.00068	CcSEcCtD
Amiodarone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000263	0.000679	CcSEcCtD
Amiodarone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000262	0.000677	CcSEcCtD
Amiodarone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000262	0.000677	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—lymphatic system cancer	0.00026	0.000673	CcSEcCtD
Amiodarone—Vomiting—Bleomycin—lymphatic system cancer	0.00026	0.000671	CcSEcCtD
Amiodarone—Rash—Bleomycin—lymphatic system cancer	0.000257	0.000665	CcSEcCtD
Amiodarone—Dermatitis—Bleomycin—lymphatic system cancer	0.000257	0.000665	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000257	0.000663	CcSEcCtD
Amiodarone—Asthenia—Carmustine—lymphatic system cancer	0.000256	0.000661	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—lymphatic system cancer	0.000254	0.000657	CcSEcCtD
Amiodarone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000251	0.000648	CcSEcCtD
Amiodarone—Sweating—Methotrexate—lymphatic system cancer	0.000248	0.000641	CcSEcCtD
Amiodarone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000244	0.000631	CcSEcCtD
Amiodarone—Asthenia—Vincristine—lymphatic system cancer	0.000244	0.000631	CcSEcCtD
Amiodarone—Diarrhoea—Carmustine—lymphatic system cancer	0.000244	0.00063	CcSEcCtD
Amiodarone—Nausea—Bleomycin—lymphatic system cancer	0.000242	0.000627	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000242	0.000624	CcSEcCtD
Amiodarone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000238	0.000614	CcSEcCtD
Amiodarone—Dizziness—Carmustine—lymphatic system cancer	0.000236	0.000609	CcSEcCtD
Amiodarone—Diarrhoea—Vincristine—lymphatic system cancer	0.000233	0.000602	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—lymphatic system cancer	0.000232	0.0006	CcSEcCtD
Amiodarone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000227	0.000586	CcSEcCtD
Amiodarone—Vomiting—Carmustine—lymphatic system cancer	0.000227	0.000586	CcSEcCtD
Amiodarone—Dizziness—Vincristine—lymphatic system cancer	0.000225	0.000581	CcSEcCtD
Amiodarone—Rash—Carmustine—lymphatic system cancer	0.000225	0.000581	CcSEcCtD
Amiodarone—Dermatitis—Carmustine—lymphatic system cancer	0.000224	0.00058	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—lymphatic system cancer	0.000224	0.000579	CcSEcCtD
Amiodarone—Headache—Carmustine—lymphatic system cancer	0.000223	0.000577	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00022	0.000568	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—lymphatic system cancer	0.000217	0.00056	CcSEcCtD
Amiodarone—Vomiting—Vincristine—lymphatic system cancer	0.000216	0.000559	CcSEcCtD
Amiodarone—Rash—Vincristine—lymphatic system cancer	0.000214	0.000554	CcSEcCtD
Amiodarone—Dermatitis—Vincristine—lymphatic system cancer	0.000214	0.000554	CcSEcCtD
Amiodarone—Headache—Vincristine—lymphatic system cancer	0.000213	0.000551	CcSEcCtD
Amiodarone—Nausea—Carmustine—lymphatic system cancer	0.000212	0.000547	CcSEcCtD
Amiodarone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000211	0.000544	CcSEcCtD
Amiodarone—Rash—Mitoxantrone—lymphatic system cancer	0.000209	0.00054	CcSEcCtD
Amiodarone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000209	0.000539	CcSEcCtD
Amiodarone—Headache—Mitoxantrone—lymphatic system cancer	0.000208	0.000536	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—lymphatic system cancer	0.000205	0.000531	CcSEcCtD
Amiodarone—Erythema—Methotrexate—lymphatic system cancer	0.000202	0.000523	CcSEcCtD
Amiodarone—Nausea—Vincristine—lymphatic system cancer	0.000202	0.000522	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000198	0.000512	CcSEcCtD
Amiodarone—Nausea—Mitoxantrone—lymphatic system cancer	0.000197	0.000509	CcSEcCtD
Amiodarone—Back pain—Methotrexate—lymphatic system cancer	0.000196	0.000506	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—lymphatic system cancer	0.000191	0.000493	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000188	0.000485	CcSEcCtD
Amiodarone—Malaise—Methotrexate—lymphatic system cancer	0.000182	0.000471	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—lymphatic system cancer	0.000182	0.00047	CcSEcCtD
Amiodarone—Cough—Methotrexate—lymphatic system cancer	0.000176	0.000456	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—lymphatic system cancer	0.00017	0.00044	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—lymphatic system cancer	0.000166	0.00043	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000165	0.000427	CcSEcCtD
Amiodarone—Infection—Methotrexate—lymphatic system cancer	0.000164	0.000424	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000162	0.000418	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—lymphatic system cancer	0.00016	0.000414	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00016	0.000412	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—lymphatic system cancer	0.000157	0.000407	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—lymphatic system cancer	0.000154	0.000399	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—lymphatic system cancer	0.000149	0.000386	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000148	0.000383	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000147	0.00038	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000145	0.000376	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000143	0.000371	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000142	0.000368	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—lymphatic system cancer	0.000142	0.000368	CcSEcCtD
Amiodarone—Pain—Methotrexate—lymphatic system cancer	0.000141	0.000365	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000136	0.000352	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000135	0.000349	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—lymphatic system cancer	0.000131	0.000339	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—lymphatic system cancer	0.00013	0.000337	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—lymphatic system cancer	0.00013	0.000337	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000122	0.000314	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—lymphatic system cancer	0.000118	0.000306	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—lymphatic system cancer	0.000117	0.000302	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000113	0.000292	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—lymphatic system cancer	0.000109	0.000282	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—lymphatic system cancer	0.000105	0.000271	CcSEcCtD
Amiodarone—Rash—Methotrexate—lymphatic system cancer	0.000104	0.000269	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—lymphatic system cancer	0.000104	0.000269	CcSEcCtD
Amiodarone—Headache—Methotrexate—lymphatic system cancer	0.000103	0.000267	CcSEcCtD
Amiodarone—Nausea—Methotrexate—lymphatic system cancer	9.8e-05	0.000253	CcSEcCtD
